UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000049381 |
|---|---|
| Receipt number | R000056212 |
| Scientific Title | Observational Study of Physicians' Perceptions of Hypertension Treatment with a Hypertension Treatment Aid App |
| Date of disclosure of the study information | 2022/11/01 |
| Last modified on | 2023/08/04 12:39:57 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Observational Study of Physicians' Perceptions of Hypertension Treatment with a Hypertension Treatment Aid App
Acronym
HERB-DP Study
Scientific Title
Observational Study of Physicians' Perceptions of Hypertension Treatment with a Hypertension Treatment Aid App
Scientific Title:Acronym
HERB-DP Study
Region
| Japan |
Condition
Condition
Hypertension
Classification by specialty
| Medicine in general | Cardiology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Determine the impact of CureApp HT on the sharing of blood pressure targets and treatment objectives between physicians and patients.
Basic objectives2
Others
Basic objectives -Others
Physician Perception Survey
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
sharing of blood pressure targets
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Physicians with experience treating essential hypertension
Physicians who can use CureApp HT
Key exclusion criteria
Previously treated with CureAppHT
Has had a repeat visit for treatment with CureAppHT prior to participation in this study
Target sample size
300
Research contact person
Name of lead principal investigator
| 1st name | Tomohiro |
| Middle name | |
| Last name | Katsuya |
Organization
Katsuyaiin
Division name
Katsuyaiin
Zip code
6600052
Address
2-17-21,Nanamatsucho,Amagasaki-si,Hyogo
TEL
06-6416-1684
tkatsuya@iris.eonet.ne.jp
Public contact
Name of contact person
| 1st name | Fumi |
| Middle name | |
| Last name | Hisaki |
Organization
CureApp,inc
Division name
Medical&RegulatoryAffairs Department
Zip code
1030001
Address
4F12-5,Nihonbashikodenmacho,Chio-ku,Tokyo.Japan
TEL
0362310183
Homepage URL
fumi.hisaki@cureapp.jp
Sponsor or person
Institute
katsuyaiin
Institute
Department
Personal name
Funding Source
Organization
CureApp,inc.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
KitamachiShinryojo rinrishinsaiinkai
Address
1-1-3,KichijojiKitamachi,Musashino-si.Tokyo
Tel
03-6779-8116
chi-pr-ec-kitamachi@cmicgroup.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2022 | Year | 11 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
152
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2022 | Year | 10 | Month | 06 | Day |
Date of IRB
| 2022 | Year | 10 | Month | 26 | Day |
Anticipated trial start date
| 2022 | Year | 11 | Month | 01 | Day |
Last follow-up date
| 2024 | Year | 08 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Status of sharing blood pressure targets with patients
Status of sharing the goal of hypertension treatment with the patient
Management information
Registered date
| 2022 | Year | 10 | Month | 31 | Day |
Last modified on
| 2023 | Year | 08 | Month | 04 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056212
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
